Regulatory Issues

Inspire Medical Investors Press Class Action Over Inspire V Rollout With Lead-Plaintiff Deadline Jan. 5

The suit claims the company overstated launch readiness and demand before August disclosures on training, billing and inventory problems that preceded a steep guidance cut and stock slide.